{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:17:39Z","timestamp":1778077059778,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003032","name":"Association Nationale de la Recherche et de la Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Statistics & Data Analysis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.csda.2026.108379","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:49:14Z","timestamp":1774338554000},"page":"108379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Optimising covariate allocation at design stage using fisher information matrix for non-linear mixed effects models in pharmacometrics"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0048-5998","authenticated-orcid":false,"given":"Lucie","family":"Fayette","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7551-0758","authenticated-orcid":false,"given":"Karl","family":"Brendel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-1275","authenticated-orcid":false,"given":"France","family":"Mentr\u00e9","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.csda.2026.108379_bib0001","series-title":"Optimum Experimental Designs, with SAS","volume":"Vol. 34","author":"Atkinson","year":"2007"},{"issue":"14","key":"10.1016\/j.csda.2026.108379_bib0002","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/sim.3573","article-title":"Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic\/pharmacodynamic model","volume":"28","author":"Bazzoli","year":"2009","journal-title":"Stat. Med."},{"issue":"3","key":"10.1016\/j.csda.2026.108379_bib0003","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/biom.12660","article-title":"Optimum designs for non-linear mixed effects models in the presence of covariates","volume":"73","author":"Bogacka","year":"2017","journal-title":"Biometrics"},{"key":"10.1016\/j.csda.2026.108379_bib0004","series-title":"Algorithms for Minimization Without Derivatives","author":"Brent","year":"2013"},{"key":"10.1016\/j.csda.2026.108379_bib0005","article-title":"Exact upper bound for copulas with a given diagonal section","volume":"480","author":"Bukov\u0161ek","year":"2024","journal-title":"Fuzzy Sets Syst."},{"issue":"1","key":"10.1016\/j.csda.2026.108379_bib0006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02592073","article-title":"Projected gradient methods for linearly constrained problems","volume":"39","author":"Calamai","year":"1987","journal-title":"Math. Program."},{"issue":"6","key":"10.1016\/j.csda.2026.108379_bib0007","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/0004563213492320","article-title":"The performances of the cockcroft-gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance","volume":"50","author":"Chin","year":"2013","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.csda.2026.108379_bib0008","unstructured":"Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), 2009\u20132020. National health and nutrition examination survey data. Hyattsville, MD: U.S. department of health and human services, centers for disease control and prevention. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/default.aspx."},{"key":"10.1016\/j.csda.2026.108379_bib0009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.fss.2014.10.030","article-title":"Characterization of copulas with given diagonal and opposite diagonal sections","volume":"284","author":"de Amo","year":"2016","journal-title":"Fuzzy Sets Syst."},{"key":"10.1016\/j.csda.2026.108379_bib0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10928-005-2102-z","article-title":"Robust population pharmacokinetic experiment design","volume":"32","author":"Dodds","year":"2005","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"7","key":"10.1016\/j.csda.2026.108379_bib0011","first-page":"2121","article-title":"Adaptive subgradient methods for online learning and stochastic optimization","volume":"12","author":"Duchi","year":"2011","journal-title":"J. Mach. Learn. Res."},{"issue":"4","key":"10.1016\/j.csda.2026.108379_bib0012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1208\/s12248-025-01066-1","article-title":"Assessing the impact of multiple imputation algorithms on pharmacokinetic model performance: a simulation-based study","volume":"27","author":"Duflot","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.csda.2026.108379_bib0013","unstructured":"EMA, 2005. Guideline on the evaluation of the pharmacokinetics of medicinal products in patients with impaired hepatic functionhttps:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-evaluation-pharmacokinetics-medicinal-products-patients-impaired-hepatic-function_en.pdf."},{"key":"10.1016\/j.csda.2026.108379_bib0014","unstructured":"EMA, 2016. Guideline on the evaluation of the pharmacokinetics of medicinal products in patients with decreased renal functionhttps:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-evaluation-pharmacokinetics-medicinal-products-patients-decreased-renal-function_en.pdf."},{"issue":"4","key":"10.1016\/j.csda.2026.108379_bib0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10928-025-09987-2","article-title":"Using fisher information matrix to predict uncertainty in covariate effects and power to detect their relevance in non-linear mixed effect models in pharmacometrics","volume":"52","author":"Fayette","year":"2025","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"4","key":"10.1016\/j.csda.2026.108379_bib0016","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1208\/s12248-023-00810-9","article-title":"Robust and adaptive two-stage designs in nonlinear mixed effect models","volume":"25","author":"Fayette","year":"2023","journal-title":"AAPS J."},{"key":"10.1016\/j.csda.2026.108379_bib0017","unstructured":"FDA, 2003. Guidance for industry pharmacokinetics in patients with impaired hepatic function - study design, data analysis, and impact on dosing and labelinghttps:\/\/www.fda.gov\/media\/71311\/download."},{"key":"10.1016\/j.csda.2026.108379_bib0018","unstructured":"FDA, 2022. Guidance for industry population pharmacokineticshttps:\/\/www.fda.gov\/media\/128793\/download."},{"key":"10.1016\/j.csda.2026.108379_bib0019","unstructured":"FDA, 2024. Guidance for industry pharmacokinetics in patients with impaired renal function - study design, data analysis, and impact on dosinghttps:\/\/www.fda.gov\/media\/78573\/download."},{"issue":"6","key":"10.1016\/j.csda.2026.108379_bib0020","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/10543406.2011.580484","article-title":"Comparison of robust criteria for d-optimal designs","volume":"22","author":"Foo","year":"2012","journal-title":"J. Biopharm. Stat."},{"issue":"1","key":"10.1016\/j.csda.2026.108379_bib0021","doi-asserted-by":"crossref","first-page":"339","DOI":"10.32614\/RJ-2016-024","article-title":"Statmod: probability calculations for the inverse gaussian distribution","volume":"8","author":"Giner","year":"2016","journal-title":"R J."},{"issue":"106","key":"10.1016\/j.csda.2026.108379_bib0022","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1090\/S0025-5718-69-99647-1","article-title":"Calculation of gauss quadrature rules","volume":"23","author":"Golub","year":"1969","journal-title":"Math. Comput."},{"key":"10.1016\/j.csda.2026.108379_bib0023","unstructured":"Guo, Y., Guo, T., van Hasselt, J. G. C., Zwep, L. B., 2024a. Pmxcopula - r package for copula-based covariate simulation. PAGE 32, Abstr 10989 www.page-meeting.org\/?abstract=10989."},{"key":"10.1016\/j.csda.2026.108379_bib0024","first-page":"1","article-title":"Generation of realistic virtual adult populations using a model-based copula approach","author":"Guo","year":"2024","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"9","key":"10.1016\/j.csda.2026.108379_bib0025","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1088\/0034-4885\/43\/9\/002","article-title":"Monte carlo theory and practice","volume":"43","author":"James","year":"1980","journal-title":"Rep. Prog. Phys."},{"issue":"S11","key":"10.1016\/j.csda.2026.108379_bib0026","doi-asserted-by":"crossref","first-page":"228S","DOI":"10.1038\/oby.2001.123","article-title":"The worldwide obesity epidemic","volume":"9","author":"James","year":"2001","journal-title":"Obes. Res."},{"key":"10.1016\/j.csda.2026.108379_bib0027","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1208\/s12248-012-9320-2","article-title":"Covariate pharmacokinetic model building in oncology and its potential clinical relevance","volume":"14","author":"Joerger","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.csda.2026.108379_bib0028","doi-asserted-by":"crossref","unstructured":"Karline Soetaert, Karel Van den Meersche, Dick van Oevelen, 2009. limSolve: solving Linear Inverse Models. R package 1.5.1.","DOI":"10.32614\/CRAN.package.limSolve"},{"key":"10.1016\/j.csda.2026.108379_bib0029","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1007\/s11095-015-1693-3","article-title":"Influence of the size of cohorts in adaptive design for nonlinear mixed effects models: an evaluation by simulation for a pharmacokinetic and pharmacodynamic model for a biomarker in oncology","volume":"32","author":"Lestini","year":"2015","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.csda.2026.108379_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10543406.2019.1607367","article-title":"Robust designs in longitudinal studies accounting for parameter and model uncertainties\u2013application to count data","volume":"30","author":"Loingeville","year":"2020","journal-title":"J. Biopharm. Stat."},{"issue":"4","key":"10.1016\/j.csda.2026.108379_bib0031","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1137\/120895093","article-title":"Computing optimal experimental designs via interior point method","volume":"34","author":"Lu","year":"2013","journal-title":"SIAM J. Matrix Anal. Appl."},{"issue":"2","key":"10.1016\/j.csda.2026.108379_bib0032","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1145\/355637.355640","article-title":"Local versus global strategies for adaptive quadrature","volume":"1","author":"Malcolm","year":"1975","journal-title":"ACM Trans. Math. Software (TOMS)"},{"issue":"6","key":"10.1016\/j.csda.2026.108379_bib0033","first-page":"1","article-title":"Current use and developments needed for optimal design in pharmacometrics: a study performed among DDMore\u2019s european federation of pharmaceutical industries and associations members","volume":"2","author":"Mentr\u00e9","year":"2013","journal-title":"CPT: Pharmacometrics Syst. Pharmacol."},{"issue":"2","key":"10.1016\/j.csda.2026.108379_bib0034","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/biomet\/84.2.429","article-title":"Optimal design in random-effects regression models","volume":"84","author":"Mentre","year":"1997","journal-title":"Biometrika"},{"key":"10.1016\/j.csda.2026.108379_bib0035","unstructured":"Mentr\u00e9, F., Leroux, R., Seurat, J., Fayette, L., 2024. PFIM: Population Fisher Information Matrix. R package version 6.1. https:\/\/CRAN.R-project.org\/package=PFIM."},{"issue":"9","key":"10.1016\/j.csda.2026.108379_bib0036","first-page":"1","article-title":"Basic concepts in population modeling, simulation, and model-based drug development","volume":"1","author":"Mould","year":"2012","journal-title":"CPT: Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.csda.2026.108379_bib0037","unstructured":"Nagler, T., Vatter, T., 2021. Rvinecopulib: high performance algorithms for vine copula modeling. R package version 0.5 5(1). https:\/\/CRAN.R-project.org\/package=rvinecopulib."},{"key":"10.1016\/j.csda.2026.108379_bib0038","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.csda.2014.06.011","article-title":"Evaluation of the fisher information matrix in nonlinear mixed effect models using adaptive gaussian quadrature","volume":"80","author":"Nguyen","year":"2014","journal-title":"Comput. Stat. Data Anal."},{"issue":"1","key":"10.1016\/j.csda.2026.108379_bib0039","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bcp.12352","article-title":"Methods and software tools for design evaluation in population pharmacokinetics\u2013pharmacodynamics studies","volume":"79","author":"Nyberg","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.csda.2026.108379_bib0040","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1016\/j.csda.2006.10.003","article-title":"Quasi-monte carlo estimation in generalized linear mixed models","volume":"51","author":"Pan","year":"2007","journal-title":"Comput. Stat. Data Anal."},{"issue":"4","key":"10.1016\/j.csda.2026.108379_bib0041","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/biomet\/79.4.763","article-title":"Efficient rounding of approximate designs","volume":"79","author":"Pukelsheim","year":"1992","journal-title":"Biometrika"},{"issue":"29","key":"10.1016\/j.csda.2026.108379_bib0042","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1200\/JCO.2010.30.2307","article-title":"Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a national cancer institute organ dysfunction working group study","volume":"28","author":"Ramalingam","year":"2010","journal-title":"J. Clinical Oncol."},{"issue":"28","key":"10.1016\/j.csda.2026.108379_bib0043","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1002\/sim.2910","article-title":"Design in nonlinear mixed effects models: optimization using the fedorov\u2013wynn algorithm and power of the wald test for binary covariates","volume":"26","author":"Retout","year":"2007","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.csda.2026.108379_bib0044","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1081\/BIP-120019267","article-title":"Further developments of the fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics","volume":"13","author":"Retout","year":"2003","journal-title":"J. Biopharm. Stat."},{"issue":"4","key":"10.1016\/j.csda.2026.108379_bib0045","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/biostatistics\/kxw020","article-title":"An MCMC method for the evaluation of the fisher information matrix for non-linear mixed effect models","volume":"17","author":"Riviere","year":"2016","journal-title":"Biostatistics"},{"issue":"6","key":"10.1016\/j.csda.2026.108379_bib0046","first-page":"1016","article-title":"Determination of ideal body weight for drug dosage calculations","volume":"40","author":"Robinson","year":"1983","journal-title":"Am. J. Hospital Pharm."},{"issue":"3","key":"10.1016\/j.csda.2026.108379_bib0047","doi-asserted-by":"crossref","DOI":"10.1214\/08-STS269","article-title":"Handling covariates in the design of clinical trials","volume":"23","author":"Rosenberger","year":"2008","journal-title":"Stat. Sci."},{"issue":"3","key":"10.1016\/j.csda.2026.108379_bib0048","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1214\/aoms\/1177729394","article-title":"Remarks on a multivariate transformation","volume":"23","author":"Rosenblatt","year":"1952","journal-title":"Ann. Math. Stat."},{"issue":"5","key":"10.1016\/j.csda.2026.108379_bib0049","first-page":"710","article-title":"Covariate modeling in pharmacometrics: general points for consideration","volume":"13","author":"Sanghavi","year":"2024","journal-title":"CPT: Pharmacometrics Syst. Pharmacol."},{"issue":"3","key":"10.1016\/j.csda.2026.108379_bib0050","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/0962280219850588","article-title":"Robust designs accounting for model uncertainty in longitudinal studies with binary outcomes","volume":"29","author":"Seurat","year":"2020","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.csda.2026.108379_bib0051","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10928-016-9499-4","article-title":"The effect of fisher information matrix approximation methods in population optimal design calculations","volume":"43","author":"Str\u00f6mberg","year":"2016","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.csda.2026.108379_bib0052","series-title":"R: A Language and Environment for Statistical Computing","year":"2013"},{"key":"10.1016\/j.csda.2026.108379_bib0053","series-title":"R: A Language and Environment for Statistical Computing","year":"2021"},{"key":"10.1016\/j.csda.2026.108379_bib0054","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.csda.2016.10.011","article-title":"A new method for evaluation of the fisher information matrix for discrete mixed effect models using monte carlo sampling and adaptive gaussian quadrature","volume":"111","author":"Ueckert","year":"2017","journal-title":"Comput. Stat. Data Anal."},{"issue":"3","key":"10.1016\/j.csda.2026.108379_bib0055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0163-7258(81)90097-8","article-title":"History of pharmacokinetics","volume":"12","author":"Wagner","year":"1981","journal-title":"Pharmacol. Ther."}],"container-title":["Computational Statistics & Data Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167947326000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167947326000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:42:53Z","timestamp":1778074973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167947326000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"alternative-id":["S0167947326000484"],"URL":"https:\/\/doi.org\/10.1016\/j.csda.2026.108379","relation":{},"ISSN":["0167-9473"],"issn-type":[{"value":"0167-9473","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimising covariate allocation at design stage using fisher information matrix for non-linear mixed effects models in pharmacometrics","name":"articletitle","label":"Article Title"},{"value":"Computational Statistics & Data Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csda.2026.108379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108379"}}